STTK Shattuck Labs, Inc.: institutional ownership and insider trading
116 funds reported holding $599M of Shattuck Labs, Inc. in their latest 13F filings; in Q2 2026 funds net bought $198M, with 38 new positions and 18 funds selling out; over the last 12 months insiders bought $250K and sold $592K on the open market.
Famous investors holding STTK
- Renaissance Technologies (Renaissance Technologies): $5.16M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $1.35M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.29M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $209K, 0.0% of the portfolio
Largest institutional holders of STTK
- T. Rowe Price Investment Management, Inc. — $93.2M
- ADAGE CAPITAL PARTNERS GP, L.L.C. — $56.4M
- Redmile Group, LLC — $47.8M
- ORBIMED ADVISORS LLC — $43.8M
- Prosight Management, LP — $41.3M
- BlackRock, Inc. (BLK) — $27.3M
- Frazier Life Sciences Management, L.P. — $26.0M
- NEXTBio Capital Management LP — $25.9M
- Deep Track Capital, LP — $25.7M
- VANGUARD CAPITAL MANAGEMENT LLC — $22.3M
Recent STTK insider trades
- Jul 2, 2026: Shukla Abhinav A. sold 410 shares ($2.87K)
- Jul 1, 2026: Shukla Abhinav A. sold 23,465 shares ($166K)
- Jun 30, 2026: Pandite Arundathy N. sold 30,000 shares ($210K)
- Jun 9, 2026: Siegall Clay B bought 62,500 shares ($250K)
5%+ owners
- T. Rowe Price Investment Management, Inc.: 15.3% (Schedule 13G/A, filed Aug 14, 2026)
- ORBIMED ADVISORS LLC: 10.0% (Schedule 13D/A, filed Jun 15, 2026)
- Redmile Group, LLC: 9.9% (Schedule 13D/A, filed Jul 17, 2026)
- Deep Track Capital, LP: 5.2% (Schedule 13G, filed Jun 17, 2026)